中文文獻
卓士傑、李春璟、李文賢、朱俊源、許?禷W、蘇河名、…、許勝雄 (2014)。現今頑固型高血壓的盛行率、可能致病機轉與相關處置。內科學誌,25,231-237。
陳勤仁 (2012)。學名藥各通路成功擴散之關鍵因素探討 ─以高血壓用藥為例。國立台北大學企業管理學系碩士論文,未出版,臺北市。林能傑 (2009)。慢性腎臟病合併高血壓的藥物治療。台灣醫界,52(9),16-20。
謝君儀、鄭昌綺、方基存 (2009)。降血壓藥物在透析患者的使用。透析常見用藥資訊專輯,21(3),152-156。
羅瑋萱 (2005)。血管張力素轉換酶抑制劑與血管張力素受體阻斷劑在腹膜透析患者之心血管疾病和殘餘腎功能的保護效果。國立成功大學臨床藥學研究所碩士論文,未出版,臺南市。蘭淑貞 (2011)。得舒(DASH)營養教育介入對高血壓者的營養知識飲食行為、自我效能和血壓的影響。台北醫學大學保健營養學系碩士論文,未出版,臺北市。
傅振宗、楊文琴 (2002)。糖尿病患的高血壓治療新趨勢。J Intern Med Taiwan,13,215-224。
林少琳、徐祥清、劉俊鵬、姜洪霆(2001)。鬱血性心臟衰竭之最新藥物治療。J Intern Med Taiwan,12,101-110。
英文文獻
Aram V. Chobanian. (2003). The Seventh Report of the Joint National Committee on
Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Institutes of Health National Heart, Lung, and Blood Institute, 1-34.
Alan S. Go, Dariush Mozaffarian, Véronique L. Roger, Emelia J. Benjamin, Jarett D. Berry. (2014). Heart Disease and Stroke Statistics—2014 Update A Report From the American Heart Association. American Heart Association Journals,128, 1-267.
Allan Collins, Robert Foley, Blanche Chavers, David Gilbertson, Charles Herzog, Bertram
Kasiske et al. (2002).USRDS 2002 Annual Data Report:Atlas of End-Stage Renal Disease in the United States. Bethesda,Maryland: National Institutes of Health, National Institute of Diabetesand Digestive and Kidney Diseases. United States Renal Data System.
Bertrand Dussol, Julie Moussi-Frances, Sophie Morange, Claude Somma-Delpero,
Olivier Mundler, Yvon Berland. (2005). A randomized trial of furosemide vs hydrochlorothiazide in patients with chronic renal failure and hypertension. Nephrol Dial Transplant, 20,349-353.
Bruce M. Psaty, Nicholas L. Smith, David S. Siscovick et al. (1997). Health Outcomes Associated With Antihypertensive Therapies Used as First-Line Agents A Systematic Review and Meta-analysis. Journal of the American Medical Association, 227(9), 740-745.
Bo Carlberg, Ola Samuelsson, Lars Hjalmar Lindholm. (2004). Atenolol in hypertension: is it a wise choice? The Lancet Medical Journal, 364, 1684-1689.
Costas Tsioufis, Alexandros Kasiakogias, Athanasios Kordalis, Kyriakos Dimitriadis,
Costas Thomopoulos, Dimitrios Tsiachris, Panagiotis Vasileiou, Michalis Doumas,
Thomas Makris, Vasilios Papademetriou, Ioannis Kallikazaros, George Bakris &
Christodoulos Stefanadis. (2014). Dynamic resistant hypertension patterns as predictors
of cardiovascularmorbidity: a 4-year prospective study. Journal of Hypertension,
32,415-422.
Christopher B. Brady, Avron Spiro, J. Michael Gaziano. (2005). Effects of Age and Hypertension Status on Cognition: The Veterans Affairs Normative Aging Study. Neuropsychology, 19(6), 770-777.
Chern-En Chiang, Tzung-Dau Wang, Kwo-Chang Ueng, Tsung-Hsien Lin, Hung-I Yeh,
Chung-Yin Chen, Yih-Jer Wu, Wei-Chuan Tsai, Ting-Hsing Chao, Chen-Huan Chen, Pao-Hsien Chu, Chia-Lun Chao, Ping-Yen Liu, Shih-Hsien Sung, Hao-Min Cheng, Kang-Ling Wang, Yi-Heng Li, Fu-Tien Chiang, Jyh-Hong Chen, Wen-Jone Chen, San-Jou Yeh, Shing-Jong Lin. (2014). 2015 Guidelines of the Taiwan Society of Cardiology and the Taiwan Hypertension Society for the Management of Hypertension. Journal of the Chinese Medical Association, 1-47.
Carlene M.M. Lawes, Derrick A. Bennett, Valery L. Feigin, Anthony Rodgers, (2004). Blood Pressure and Stroke: An Overview of Published Reviews. American Heart Association, 35, 776-785.
Chen-Ying Hung, Kuo-Yang Wang, Tsu-Juey Wu, Yu-Cheng Hsieh, Jin-Long Huang, EI-Wui Loh, Ching-Heng Lin. (2014). Resistant Hypertension, Patient Characteristics, and Risk of Stroke. Plosone,9(8), 1-7.
Cushman WC, Ford CE, Cutler JA, Margolis KL, Davis BR, Grimm RH, etal. (2002). Success and predictors of blood pressure control in diverse NorthAmerican settings: the Antihypertensive and LipidLowering Treatment to Prevent Heart Attack Trial (ALLHAT).The Journal of Clinical Hypertension, 4, 393 405.
Elisabeta Bâdilâ, Ana Maria Daraban, Emma Ţintea,Cristina Manuela Tîrziu, Mihaela Hostiuc & Daniela Bartoş. (2013). Resistant Arterial Hypertension–Yet another Problem for Clinical Practice. Romanian Journal of Internal Medicine, 51(1), 9–18.
Edward D. Freis. (1974). The Veterans Administration Cooperative Study on Antihypertensive Agents. Implications for Stroke Prevention. American Heart Association Journals, 5, 76-77.
F. Kanat, H. Vatansev, T. Teke. (2007). Diuretics, plasma brain natriuretic peptide and chronic obstructive pulmonary disease. The Netherlands Journal of Medicine, 8(65),296-300.
Giuliano Tocci, Allegra Battistoni, Jasmine Passerini, Maria Beatrice Musumeci, Pietro Francia, Andrea Ferrucci & Massimo Volpe. (2014). Calcium Channel Blockers and Hypertension, 1-10.
George L. Bakris, Matthew R. Weir, Shahnaz Shanifar, Zhongxin Zhang, Janice Douglas, David J. van Dijk, Barry M. Brenner. (2003). Effects of Blood Pressure Level on Progression of Diabetic Nephropathy. Archives of Internal Medicine. 163, 1555-1565.
Giuseppe Faraco and Costantino Iadecola,(2013). Hypertension: a harbinger of stroke and dementia. Hypertension, 62(5),1-15.
Hsueh WA, Wyne K (2011). Renin-Angiotensin-aldosterone system in diabetes and hypertension. J Clin Hypertens (Greenwich), 13: 224–237.
James J DiNicolantonio, Hassan Fares, Asfandyar K Niazi, Saurav Chatterjee et al. (2015). β-Blockers in hypertension, diabetes,heart failure and acute myocardial infarction: a review of the literature. American Heart Association Journals, 2, 2-12.
Jennifer L. Bragg-Gresham,Rachel B. Fissell, Nancy A. Mason, Pharm et al.(2007). Diuretic Use, Residual Renal Function, and Mortality Among Hemodialysis Patients in the Dialysis Outcomes and Practice Pattern Study (DOPPS). American Journal of Kidney Diseases, 49(3), 426-431.
Kannel WB, Schwartz MJ, McNamara PM, (1969).Blood pressure and risk of coronary heart disease: the Framingham study. Dis Chest, 56, 43–52.
Liu, P.H. and Wang, J.D. (2008). Antihypertensive medication prescription patterns and time trends for newly-diagnosed uncomplicated hypertension patients in Taiwan. BMC Health Services Research, 8(133), 1-11.
M. Salman Singapuri & Janice P. Lea. (2010). Management of Hypertension in the End-Stage Renal Disease Patient. Journal of Clinical Outcomes Management, 17(2), 87-95.
Medical Research Council Working Party. (1992). Medical Research Council trial of treatment of hypertension in older adults: principal results. BMJ, 204, 405–412.
Marvin Moser, Edward J. Roccella, (2013). The Treatment of Hypertension: A Remarkable Success Story. J Clin Hypertens, 15, 88–91.
Michael Doumas, Costas Tsioufis, Charles Faselis, Antonios Lazaridis, Haris Grassos & Vasilios Papademetriou. (2014). Non-interventional management of resistant hypertension. World Journal of Cardiology, 6(10), 1080-1090.
Musini VM, Nazer M, Bassett K, Wright JM. (2014). Blood pressure-lowering efficacy of monotherapy with thiazide diuretics for primary hypertension. Cochrane Database of Systematic Reviews, 5.
M. Salman Singapuri, Janice P. Lea, MD.(2010). Management of Hypertension in the End-Stage Renal Disease Patient. Journal of Clinical Outcomes Management,2(17), 87-95.
Nathan D. Wong & Stanley S. Franklin. (2014).American Society of Hypertension Self-Assessment Guide Basic Science Epidemiology of Hypertension. Journal of the American Society of Hypertension, 8(10), 760–763.
Pamela A. Sytkowski, Ralph B. D’Agostino, Albert J. Belanger, William B. Kannel. (1996) . Secular trends in long-term sustained hypertension, long-term treatment and cardiovascular mortality. The Framingham Heart Study 1950–1990. Circulation, 93, 697–703.
Pantelis A. Sarafidis, George L. Bakris, Thessaloniki, Greece & Chicago, Illinois. (2008). Resistant Hypertension - An Overview of Evaluation and Treatment. Journal of the American College of Cardiology, 52(22), 1749-1757.
Patricia M. Kearney, Megan Whelton, Kristi Reynolds, Paul K. Whelton & Jiang He. (2004).Worldwide prevalence of hypertension: a systematic review. Journal of Hypertension, 22(1), 11-19.
RB Singh, IL Suh, VP Singh, S Chaithiraphan, P Laothavorn, RG Sy, NA Babilonia, ARA Rahman, S Sheikh8, B Tomlinson & N Sarraf-Zadigan. (2000).Hypertension and stroke in Asia:prevalence, control and strategies in developing countries for prevention. Journal of Human Hypertension, 14, 749-763.
Rory Collins, Rechard Peto, Stephen MacMahon, Patrichia Hebert, Nicholas L. Fiebach, Kimberley A. Eberlein, Jon Godwin, Nawab Qizilbash, James O. Taylor, Charles H. Hennekens. (1990). Blood pressure, stroke, and coronary heart disease, II: short-term reductions in blood pressure: overview of randomized drug trials in the epidemiologic context. Lancet, 335, 827-838.
Roberto Pedrinelli, Piercarlo Ballo, Cesare Fiorentini. (2011). Hypertension and acute myocardial infarction: an overview.Journal of Cardiovascular Medicine, 3(13), 195-201.
Ruchi Kumra, Joanne M. Bargman. (2014). A Review of Diuretic Use in Dialysis Patients. Advances in Peritoneal Dialysis, 3, 116-118.
Rajiv Agarwal, Allen R. Nissenson, Daniel Batlle, Daniel W. Coyne, J. Richard Trout, David G. Warnock. (2003). Prevalence, Treatment, and Control of Hypertension in Chronic Hemodialysis Patients in the United States. The American Journal of Medicine, 115, 291-297.
Stacie L. Daugherty, J. David Powers, David J. Magid, Heather M. Tavel, Frederick A. Masoudi, Karen L. Margolis, Patrick J. O’Connor, Joe V. Selby & P. Michael Ho. (2012).
Incidence and Prognosis of Resistant Hypertension in Hypertensive Patients. Circulation,
125, 1635-1642.
Stephen D. Persell. (2011). Prevalence of Resistant Hypertension in the United States, 2003–2008. American Heart Association, 57, 1076-1080.
Stroke Association, (2012). High blood pressure and stroke.取自於http://www.stroke.org.uk/sites/default/files/files/F06_High%20blood%20pressure%20and%20stroke.pdf
The RALES investigators, (1996). Effectiveness of spironolactone added to a angiotensin-converting enzyme inhibitor and a loop diuretic for severe chronic congestive heart failure. The randomized aldosterone evaluation study (RALES), 78, 902-907.
Thamm Katharina Wolf-Maier, Richard S. Cooper, Holly Kramer, José R. Banegas, Simona Giampaoli, Michel R. Joffres, Neil Poulter, Paola Primatesta, Birgitta Stegmayr & Michael Thamm. (2004). Hypertension Treatment and Control in Five European Countries, Canada, and the United States. American Heart Association Journals, 43, 10-17.
Waichi Sato and Yuka Sato, (2013). Midkine in nephrogenesis, hypertension and kidney diseases. British Journal of Pharmacology, 171, 879–887
Wilhelmsen L,Berglund G,Elmfeldt D,Fitzsimons T et al. (1987). Beta-blockers versus diuretics in hypertensive men: main results from the HAPPHY trial. Gower Acadmic Journals, 5(5),561-572.